Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study

J Alzheimers Dis. 2017;58(3):669-674. doi: 10.3233/JAD-170104.

Abstract

We investigated the frequency of Lewy-related pathology (LRP) in the amygdala among the population-based Vantaa 85+ study. Data of amygdala samples (N = 304) immunostained with two α-synuclein antibodies (clone 42 and clone 5G4) was compared with the previously analyzed LRP and AD pathologies from other brain regions. The amygdala LRP was present in one third (33%) of subjects. Only 5% of pure AD subjects, but 85% of pure DLB subjects had LRP in the amygdala. The amygdala LRP was associated with dementia; however, the association was dependent on LRP on other brain regions, and thus was not an independent risk factor. The amygdala-predominant category was a rare (4%) and heterogeneous group.

Keywords: 80 and over; Alzheimer’s disease; Lewy body disease; Lewy-related pathology; aged; amygdala; amygdala-predominant; population-based study; α-synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Amygdala / metabolism*
  • Amygdala / pathology*
  • Female
  • Finland
  • Follow-Up Studies
  • Humans
  • Lewy Body Disease / epidemiology
  • Lewy Body Disease / metabolism
  • Lewy Body Disease / pathology
  • Logistic Models
  • Male
  • Prevalence
  • alpha-Synuclein / metabolism*

Substances

  • SNCA protein, human
  • alpha-Synuclein